Study Stopped
Methods unexpectedly required additional refinement that precluded subject enrollment.
Source of Hand Weakness After Stroke
Source of Neurally-Mediated Hand Weakness After Stroke
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to determine whether neural block and neuromuscular electrical stimulation are effective in treating finger impairment due to stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2009
Typical duration for phase_2 stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
May 21, 2009
CompletedFirst Posted
Study publicly available on registry
May 25, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedMay 5, 2014
May 1, 2014
3.9 years
May 21, 2009
May 1, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
fingertip force
force measured before and after intervention (1 week later)
Study Arms (2)
Arm 1
ACTIVE COMPARATORpersons with severe hand impairment following hemiparetic stroke
Arm 2
ACTIVE COMPARATORpersons with severe hand impairment following hemiparetic stroke
Interventions
comparison of the effect of stimulated muscle(s) on finger function
Eligibility Criteria
You may qualify if:
- clinical diagnosis of stroke;
- stroke occurred no less than 6 months prior to study;
- must have had only 1 stroke;
- must demonstrate severe hand impairment;
- must have no substantial evidence of motor and sensory deficits in non-paretic limb;
- must have no history or clinical signs of neurologic diseases other than stroke;
- must have no cognitive dysfunction that precludes comprehension of experimental tasks;
- must be able to give informed consent
You may not qualify if:
- taking medication that can increase the risk of lidocaine toxicity such as cimetidine (ulcer treatment drug), phenytoin (anticonvulsant drug), nadolol (drug for treatment of headache, hypertension, chest pain);
- taking anticoagulant medication, i.e., aspirin, coumadin;
- has a low platelet count or a bleeding disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Edward Hines, Jr. VA Hospital
Hines, Illinois, 60141-5000, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph Towles
Edward Hines Jr. VA Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 21, 2009
First Posted
May 25, 2009
Study Start
February 1, 2009
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
May 5, 2014
Record last verified: 2014-05